The epigenome-wide analysis at screening identified 17 unique CpG sites that reached epigenome-wide significance, 10 of which were located within or nearby the MAD1L1 gene and were associated with either of the four depression-related MAD1L1 SNPs (Additional file 11: Table S3 and Fig. 2). This evidence concerns the gene MAD1L1 and depressive symptom measurement.